Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
deals
fda
life sciences
national blog main
national top stories
roche
2
×
alexion pharmaceuticals
alnylam pharmaceuticals
boehringer ingelheim
cancer
cancer immunotherapy
center for medicare and medicaid services
clinical trials
companion diagnostic
daniel o'day
dicerna pharamceuticals
foundation medicine
foundationone cdx
foundationone heme
genentech
hepatitis b
hepatitis b virus
hereditary transthyretin amyloidosis
new york blog main
osimertinib
patisiran
rna interference
rucaparib (rubraca)
san francisco blog main
world health organization
What
pay
2
×
roche
acquire
agreed
big
billion
broad
caught
causing
confidence
dicerna
didn’t
disease
drug
eye
foundation
gain
gene
genentech
hepatitis
intended
medicine
medicines
momentum
morning
panels
pays
pharma
pharmaceuticals
picked
producing
profiling
protein
recently
redux
remaining
research
rest
share
stock
Language
unset
Current search:
pay
×
roche
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
